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INTRODUCTION
The protozoan parasite, Trichomonas vaginalis, is the cause of 
trichomoniasis, a common sexually transmitted disease [1]. 
The World Health Organization estimates that over half of the 
143 million new T. vaginalis infections each year involve males 
[2]. The majority of infections in men are asymptomatic and 
remain undiagnosed and untreated, and are thought to result 
in persistent prostatic infection [3]. Trichomonas vaginalis has 
been detected in prostate tissue in prostate cancer and benign 
prostatic hyperplasia (BPH), as well as in the urine of patients 
with prostatitis [4-6]. We have shown that T. vaginalis infection 
causes acute and chronic inflammation within the parenchy-
ma of the prostate gland [7], and prostate inflammation, in-
cluding the production of cytokines, appears to be a cause of 
BPH and prostate cancer [8,9]. Inflammatory mediators are 
secreted by the prostatic stroma consequent upon aging, and 
the levels of these mediators are sufficient to increase the pro-
liferative rate of both epithelial and stromal fibroblasts [10]. 
Although, inflammation may play a role in the development 
of benign proliferative diseases of the prostate such as BPH, 
the connections between inflammation, T. vaginalis infection 
and prostate enlargement are not fully understood.
Benign prostate hyperplasia (BPH) occurs clinically in about 
50% of men over the age of 70 [11]. It is not clear what elicits 
BPH, but aging may be a prerequisite for its induction [12]. 
Recently, some reports have also highlighted the key roles of 
hormonal alterations, metabolic syndrome and obesity in the 
pathogenesis of BPH [13-16].
Obesity causes many physiological problems and can in-
duce chronic inflammation [17]. In addition, infection by 
Neospora caninum, a protozoon, raises serum leptin levels and 
contributes to long-term inflammation in adipose tissue [18]. 
Adipocytes influence the endocrine system and immune re-
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Abstract: Leptin is a type of adipokine mainly produced by adipocytes and reported to be overproduced in prostate can-
cer. However, it is not known whether it stimulates the proliferation of prostate cells. In this study, we investigated whether 
benign prostatic hyperplasia epithelial cells (BPH-1 cells) infected with Trichomonas vaginalis induced the proliferation of 
prostate cells via a leptin signaling pathway. To investigate the effect of crosstalk between adipocyte leptin and inflamed 
epithelial cell in proliferation of prostate cells, adipocytes 3T3-L1 cells were incubated in conditioned medium of BPH-1 
cells infected with T. vaginalis (T. vaginalis-conditioned medium, TCM), and then the adipocyte-conditioned medium 
(ATCM) was identified to cause proliferation of prostate cells. BPH-1 cells incubated with live T. vaginalis released pro-in-
flammatory cytokines, and conditioned medium of these cells caused migration of adipocytes. When prostate stromal 
cells and BPH-1 cells were incubated with adipocyte conditioned medium containing leptin, their growth rates increased 
as did expression of the leptin receptor (known as OBR) and signaling molecules such as JAK2/STAT3, Notch and sur-
vivin. Moreover, blocking the OBR reduced this proliferation and the expression of leptin signaling molecules in response 
to ATCM. In conclusion, our findings show that inflamed BPH-1 cells infected with T. vaginalis induce the proliferation of 
prostate cells through leptin-OBR signaling. Therefore, it is likely that T. vaginalis contributes to prostate enlargement in 
BPH via adipocyte leptin released as a result of inflammation of the prostate.
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sponses through several cytokine-like mediators known as adi-
pokines. Leptin is an adipokine originally identified as a key 
molecule in the regulation of food intake and body weight. It 
interacts with other hormones and energy regulators, mediat-
ing the effects of insulin, glucagon, insulin-like growth factor, 
growth hormone, glucocorticoids, cytokines, and metabolites 
[19]. Obesity is associated with several diseases, and many re-
ports have suggested a link between leptin and cancer growth. 
Leptin also stimulates the growth of prostate, breast, lung, 
ovarian and pancreatic cancer cells [20-24]. BPH is closely 
linked to obesity, and abdominal obesity and serum leptin 
levels influence prostate growth [25] and are high-risk factors 
for clinical BPH [18]. However, the connection between BPH 
and obesity is not yet fully understood at the molecular level. 
Furthermore, it is not clear whether leptin influences the pro-
gression of BPH.
We showed previously that BPH epithelial cells that had 
been infected with T. vaginalis caused inflammation, and in-
duced the proliferation of prostate stromal cells by activating 
of mast cells [26]. Subsequently, inflammatory mediators re-
leased from the proliferating stromal cells by T. vaginalis infec-
tion were shown to induce the proliferation of BPH epithelial 
cells [27]. However, it is not known how the crosstalk between 
T. vaginalis infection and adipocytes causes the proliferation of 
prostate cells. In particular, it is not known whether leptin re-
leased from the adipocytes is directly responsible for the pro-
liferation of normal and benign prostate cells. To assess 
whether inflammation due to T. vaginalis infection in obese 
conditions is involved in the progression of BPH, we exam-
ined whether adipocyte, incubated with culture supernatants 
of BPH epithelial cells infected with T. vaginalis, induces the 
proliferation of prostate stromal and epithelial cells by pro-
duction of leptin. Our findings suggest that BPH epithelial 
cells infected with T. vaginalis induce adipocyte migration and 
activation and that in turn, the adipocytes produce leptin, 
which stimulates the proliferation of prostate cells.
MATERIALS AND METHODS
Cultivation of parasite and host cells 
Trichomonas vaginalis isolate T016, human BPH epithelial 
cell line (BPH-1 cell) and human prostate stromal cell line 
(WPMY-1 cell) were cultured as described in our previous 
study [26]. All the cells were incubated in 5% CO2 at 37˚C.
Cultivation of adipocytes
Mouse preadipocyte cells (3T3-L1 cell) were a gift from Prof. 
Jae-woo Kim (Yonsei University). They were grown in DMEM 
containing 10% bovine calf serum (BCS, Rosedale, Auckland, 
New Zealand) and 1×  penicillin-streptomycin solution. To in-
duce differentiation, 2-day post-confluent 3T3-L1 cells were 
incubated in DMEM containing 10% FBS, 0.5 mM 3-isobutyl-
1-methylxanthine, 1 μM dexamethasone, and 10 μg/ml insulin 
for 3 days. The cells were then cultured in DMEM containing 
10% FBS and insulin for another 2 days, after which they were 
grown in DMEM containing 10% FBS. Lipid droplets in the 
cells were detected by oil-red-O staining [28].
Preparation of conditioned media
To probe the effect of interactions between adipocytes and 
inflamed epithelial cells on the proliferation of prostate cells, 
in vitro co-cultures of adipocytes and BPH-1 cells infected with 
T. vaginalis were established. Conditioned media were made as 
described previously [26]. Briefly, BPH-1 cells were seeded at 
1×105 cells/well in complete medium in 12-well plates. After 
24 hr, the medium was changed to serum-free medium and 
the cells were cultured for another 24 hr to stabilize them. 
They were then incubated with or without live T. vaginalis in a 
ratio of 1:10 for 6 hr and supernatants were collected, filtered 
through 0.2 mm filters, and stored frozen. The culture super-
natants of the BPH-1 cells incubated with and without T. vagi-
nalis were named T. vaginalis-conditioned medium (TCM) and 
conditioned medium (CM), respectively. Differentiated adipo-
cytes were incubated with TCM and CM, in the same way, 
yielding the conditioned media ATCM and ACM. Final con-
centrations of the conditioned media used for various assays 
were adjusted to 10% with cell culture medium.
Measurement of cytokines 
Cytokine concentrations in conditioned media were measured 
by ELISAs. Concentrations of cytokines IL-6, CXCL8, CCL2, and 
IL-1β were measured with human ELISA sets (BD Biosciences, 
San Jose, California, USA) and concentrations of adipokines 
CXCL1, IL-6, and CCL2 were measured with mouse ELISA sets 
(BD Biosciences). Leptin levels were measured with a mouse 
leptin ELISA kit (Abcam, Cambridge, Massachusetts, USA).
Preadipocyte chemotaxis assay 
Chemotaxis was assessed using 24-well plates fitted with 
5 mm pore polycarbonate membrane inserts. The chemotactic 
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index was calculated as described in our previous study [28]. 
Briefly, the lower wells were filled with 350 ml of TCM, and 
polycarbonate membrane inserts were placed over the lower 
wells. For adhesion of the cells, the filters were pretreated with 
human plasma fibronectin (100 mg/ml) overnight at 4˚C, and 
air-dried for 30 min. The upper wells were filled with 200 ml 
of preadipocyte cell (2×105 cells/well) in serum-free medium, 
and the plates were incubated for 24 hr at 37˚C. After incuba-
tion, cells that did not migrate through the pores were wiped 
off the membranes with cotton swabs. The cells that had mi-
grated to the underside of the membrane were fixed in metha-
nol and stained with Giemsa stain solution, and 5 randomly-
selected fields per membrane were counted under a light mi-
croscope. The chemotactic index was calculated from the 
number of cells that migrated relative to the control.
Proliferation and invasion assays
To measure cell proliferation, wound healing assay and 
BrdU incorporation assay were used. For wound healing as-
says, cultured prostate cells that had reached confluence were 
wounded by scraping across the surface of the well with a ster-
ile micropipette tip. The cells were washed immediately and 
incubated in 10% ATCM for 48 hr. Before and after incuba-
tion, at least ten different fields of the wounded area of each 
sample were photographed with an inverted microscope (Lei-
ca, Las software) [26]. We used the 5-bromo-20-deoxyuridine 
(BrdU) incorporation assay to detect DNA synthesis following 
ATCM treatment of prostate cells. For the BrdU assay, prostate 
cells were seeded at 5×104/well on sterile cover glasses in 12-
well plates, allowed to adhere overnight and cultured with 
10% ATCM for 48 hr. During that time, BrdU (10 μg/ml) was 
added to the cells once a day. The cells were fixed for 10 min at 
–20˚C, and denatured for 30 min at 37˚C. For blocking and 
permeabilization, the cells were placed in blocking buffer for 
1 hr at room temperature. They were then incubated with anti-
BrdU antibody (Abcam) overnight at 4˚C, and stained with Al-
exa 594-labelled goat anti-rabbit lgG (Invitrogen, Carlsbad, 
California, USA) at 37˚C for 1 hr. They were mounted in Vecta-
shield mounting medium (Vector Laboratories, Burlingame, 
California, USA) with DAPI to visualize nuclei. Fluorescence 
was measured with a fluorescence microscope (Leica, Las soft-
ware). The invasiveness of prostate stromal cells treated with 
conditioned medium was tested according to the protocol de-
scribed in our previous report [26].
Immunofluorescence detection of the leptin receptor
The leptin receptor is known as LEP-R or OB-R and has been 
used as OBR in several papers. To observe expression of the 
leptin receptor (OBR) on the surface of prostate cells, we used 
an immunofluorescence assay [26]. Transmembrane OBR, 
which belongs to the cytokine receptor superfamily, mediates 
the effects of leptin. Prostate cells were seeded at 2×105 cells/
well on sterile cover glasses in 12-well plates and cultured in 
complete medium. After overnight incubation, the medium 
was changed to ATCM, and the cells were cultured at 37˚C for 
24 hr. They were then washed, fixed with 4% paraformalde-
hyde for 10 min at –20˚C and blocked with 0.1% normal goat 
serum for 1 hr. The cover glasses were incubated with anti-
OBR antibody (Abcam) overnight at 4˚C, washed and stained 
with Alexa 594-labelled goat anti-rabbit lgG (Invitrogen) at 
37˚C for 1 hr. The cells were mounted in Vectashield mounting 
medium (Vector Laboratories) with DAPI to visualize nuclei. 
Fluorescence was measured with a fluorescence microscope 
(Leica, Las Software).
Reverse transcription PCR (RT-PCR) and quantitative 
real-time PCR (Q-PCR)
Levels of mRNA in T. vaginalis-treated BPH-1 cells and TCM-
treated 3T3-L1 cells were measured by RT-PCR [26]. BPH-1 
cells were seeded at 2×105 cells/well in 24-well plates in culture 
medium. After overnight incubation, the medium was changed 
to serum-free medium and then live T. vaginalis was added. In 
case of 3T3-L1 cells, cells were seeded at 5×104 cells/well on 
24-well plates with the culture medium. The medium of adipo-
cytes replaced to serum-free medium with 10% TCM. mRNA 
levels of leptin signaling molecules were examined by Q-PCR 
[26]. Prostate cells were seeded at 2×105 cells/well in 24-well 
plates with culture medium. After overnight incubation, the 
medium was changed to serum-free medium with 10% ATCM. 
Anti-OBR antibody was used to block leptin signaling. After re-
action, the cells were collected and total RNA was extracted us-
ing Tri-RNA reagent (Favorgen Biotech Corp, Kaohsiung, Tai-
wan). RNA samples were reverse transcribed to cDNA using 
Maxime RT preMix (Oligo (dt) 15 Primer) (iNtRON Biotech-
nology, Sungnam, Korea), and the cDNA was used as template 
for subsequent PCR amplification using following gene-specific 
primers. Human CXCL8; 5'-GGCAGCTTCCTGATTTCTG-3', 
5 ' -CGCAGTGTGGTCCACTCTCA-3 ' ,  Human CCL2; 
5 ' -CAAGCAGAAGTGGGTTCAGGA-3 ' ,  5 ' -TCTTCG-
GAGTTTGGGTTTGC-3', Human IL-6; 5'-TGGCTGCAGGACAT-
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GACAACT-3', 5'-ATCTGAGGTGCCCATGCTACA-3', Human IL-
1β; 5'-CTGATGGCCCTAAACAGATGAAG-3', 5'-GGTCGGAGA-
TTCGTAGCAGCTGGAT-3', Human JAK2; 5'-GAGCCTATCG-
GCATGGAATA-3', 5'-ACTGCCATCCCAAGACATTC-3', Human 
STAT3; 5'-TGTGCGTATGGGAACACCTA-3', 5'-AGAAGGTC-
GTCTCCCCCTTA-3', Human Notch1; 5'-GAGGCGTG-
GCAGACTATGC-3', 5'-CTTGTACTCCGTCAGCGTGA-3', Hu-
man Jagged1; 5'-TCGGGTCAGTTCGAGTTGGA-3', 5'-AGGCA-
CACTTTGAAGTATGTGTC-3', Human Jagged2; 5'-AGCTGGAC-
GCCAATGAGTG-3', 5'-GTCGTTGACGTTGATATGGCA-3', Hu-
man survivin; 5'-TCCACTGCCCCACTGAGAAC-3', 5'-TG-
GCTCCCAGCCTTCCA-3', Mouse leptin; 5'-TGCTGCAGATAGC-
CAATGAC-3', 5'-GAGTAGAGTGAGGCTTCCAGGA-3', β-actin; 
5'-CCAGAGCAAGAGAGGTATCC-3', 5'-CTGTGGTGGT-
GAAGCTGTAG-3'. Target mRNA was amplified with Maxime 
PCR PreMix (i-StarTaq) (iNtRON Biotechnology) using a Mas-
tercycler (Eppendorf, Hamburg, Germany) for RT-PCR, and 
PCR products were separated by agarose gel electrophoresis. 
Bands were visualized with StaySafe Nucleic Acid Gel stain 
(RBC, Banqiao, New Taipei, Taiwan) and identified using an 
ExcelBand™ 100 bp+3K DNA Ladder (SMOBIO, Hsinchu, Tai-
wan). For quantitative real-time PCR, target mRNA was ampli-
fied using a LightCycler 480 SYBR Green I Master (Roche Life 
Science, Mannheim, Germany) and analyzed with the LightCy-
cler 480 Software (Roche Life Science). β-actin was used as an 
internal control.
Western blot analysis
Cells were harvested and lysed in PRO-PREP protein extrac-
tion solution (iNtRON Biotechnology). Cell lysates were 
scraped, and protein concentrations were measured with the 
Bradford assay. Equal amounts of protein were denatured in 
5×protein sample buffer (ELPIS biotech, Daejeon, Korea), 
separated by SDS-PAGE on 12% polyacrylamide gel, and 
transferred to Immun-Blot®PVDF membranes (Bio-Rad, Quar-
ry Bay, Hong Kong). The membranes were blocked with 3% 
bovine serum albumin, and probed with the following prima-
ry antibodies overnight at 4˚C: anti-leptin antibody (Abcam), 
anti-p-JAK2 antibody (Abcam), anti-p-STAT3 antibody (Cell 
signaling, Danvers, Massachusetts, USA), anti-Notch1 anti-
body (bioworld, Dublin, Ohio, USA), anti-NICD antibody 
(Abcam), anti-Jagged1 antibody (Abcam), anti-survivin anti-
body (Enzo Life Sciences, Farmingdale, New York, USA) or 
β-actin polyclonal antibody (Abcam). After washing, the 
membranes were incubated with goat anti-rabbit IgG antibody 
(H+L), HRP conjugated (Bioss Antibodies, Woburn, Massa-
chusetts, USA) for 1 hr at room temperature, blots were visual-
ized using Chemiluminescent Sensitive Plus HRP Microwell 
and/or Membrane Substrate (SurModics, Eden Prairie, Minne-
sota, USA) and signals were measured with a Chemi-Doc® 
(Bio-Rad, Hercules, California, USA) [26].
Statistical analysis
Statistical analyses were performed using SPSS statistical 
software, version 21 (IBM, Chicago, Illinois, USA). The Mann-
Whitney U test was used to compare results, and 2 tailed P-
values <0.05 were considered statistically significant. All data 
are expressed as means±SEMs of three to four independent 
experiments.
Ethical statement
This study was approved by the Institutional Review Board 
of Hanyang University Hospital (IRB No. 2019-04-011-002). 
Waiver of informed consent for this study was obtained from 
IRB based on the retrospective analyses of archived tissues and 
clinical data.
RESULTS
Cytokine production by BPH epithelial cells cocultured 
with Trichomonas vaginalis
We first examined cytokine production by BPH-1 cells incu-
bated with T. vaginalis (1:10) for 6 hr. The BPH-1 cells incubat-
ed with T. vaginalis released cytokines IL-6 (448.8 pg/ml), 
CXCL8 (548.6 pg/ml), CCL2 (435.9 pg/ml) and IL-1β (147.5 
pg/ml), and cytokine production was significantly higher than 
in the absence of T. vaginalis (P<0.05; Fig. 1A). Similarly, cyto-
kine mRNA levels of cells incubated with T. vaginalis were 
higher than those incubated without T. vaginalis (Fig. 1B). T. 
vaginalis was confirmed to cause inflammatory response in 
BPH-1 cells. Culture supernatants of BPH-1 cells incubated 
with and without T. vaginalis were designated T. vaginalis-con-
ditioned medium (TCM) and conditioned medium (CM), re-
spectively. To identify lipid droplets accumulated in the cyto-
plasm of mature adipocytes, Oil-Red O staining was per-
formed. Lipid accumulation of the adipocytes was observed in 
red (Fig. 1C).
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Migration of preadipocytes, and adipokine expression in 
adipocytes induced by TCM
Recently it was reported that pre-adipocytes are recruited 
preferentially to prostate cancer tissue rather than to surround-
ing normal prostate tissue [29]. We examined the effect of 
TCM on the migration of 3T3-L1 cells using a chemotaxis as-
say. Chemotaxis by 3T3-L1 cells exposed to TCM was signifi-
cantly greater than by cells exposed to CM (P<0.05; Fig. 2A). 
This result suggests that factors released by inflamed BPH-1 
cells infected with T. vaginalis play a role in the recruitment of 
3T3-L1 cells.
To determine whether the conditioned medium from T. 
vaginalis-stimulated BPH-1 cells (TCM) is involved in the pro-
duction of leptin by adipocyte, 3T3-L1 preadipocytes were al-
lowed to develop into mature adipocytes (Fig. 1C). The ma-
ture 3T3-L1 cells were then stimulated with TCM and found to 
release higher levels of CXCL1, IL-6, CCL2 than cells incubated 
with CM or medium only (P<0.05; Fig. 2B); especially, pro-
duction of leptin mRNA and protein was also increased by 
TCM (Fig. 2C, D). This means that the T. vaginalis-induced in-
flammatory mediators of BPH-1 cells triggered the inflamma-
tory response of adipocytes, including leptin production. The 
conditioned media from mature adipocytes incubated with 
TCM and CM were designated ATCM and ACM, respectively.
Expression of leptin receptor in prostate cells exposed to 
ATCM
The effects of leptin are mediated by the transmembrane 
leptin receptor (OBR), which belongs to the cytokine receptor 
superfamily [30]. It was also reported that OBR is expressed in 
BPH tissue [31]. To measure ATCM-induced expression of leptin 
receptor, WPMY-1 and BPH-1 cells were incubated in 10% 
ATCM, and OBR was detected by immunofluorescence micros-
copy and western blot assay. OBR levels were elevated in both 
sets of ATCM-treated cells although their levels were slightly 
lower than in cells exposed to recombinant leptin (Fig. 3).
Proliferation of prostate cells is induced by ATCM
It is not clear whether leptin could influence on the growth 
of BPH although leptin was associated with proliferation and 
invasion of prostate cancer [32]. To determine whether condi-
tioned media including leptin are involved in proliferation of 
prostate cells, BPH-1 and WPMY-1 cells were incubated with 





































Fig. 1. Cytokine production by benign prostate hyperplasia-1 (BPH-1) cells infected with Trichomonas vaginalis, and differentiation of 
preadipocytes (3T3-L1) into mature adipocytes. To examine cytokine production, BPH-1 cells were incubated with live T. vaginalis (Tv). 
Cytokines (IL-6, CXCL8, CCL2, and IL-1β) and their mRNAs were measured by ELISA (A) and RT-PCR (B), respectively. Medium, culture 
supernatant of BPH-1 cells not exposed to T. vaginalis. *P<0.05 versus w/o T. vaginalis. To identify lipid droplets accumulated in the cy-
toplasm of mature adipocytes, oil-Red O staining was performed. Lipid accumulation of the adipocytes was observed in red (C).
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Fig. 2. Migration of preadipocytes, and adipokine expression in adipocytes exposed to TCM. The effect of TCM on the migration of pre-
adipocyte was examined. The migration of 3T3-L1 cells was assessed by counting the number of cells that migrated through a mem-
brane to a lower well containing TCM or CM over 24 hr. The graph shows relative preadipocyte migration (A). Production of adipokines 
by mature adipocytes exposed to TCM was measured by ELISA (B). mRNA and protein levels of leptin produced by mature adipocytes 
exposed to TCM were detected by RT-PCR (C) and western blotting (D), respectively. TCM, culture supernatant from BPH epithelial cells 
stimulated with T. vaginalis; CM, culture supernatant from BPH epithelial cells; Medium, DMEM medium. *P<0.05.
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Fig. 3. Increased expression of the leptin receptor in prostate cells treated with ATCM. Leptin receptor (OBR) expression in prostate cells 
treated with ATCM was observed by immunofluorescence and western blot assays. Expression of OBR increased in prostate stromal 
cells (A, B) and BPH epithelial (C, D) cells exposed to ATCM. ATCM, culture supernatant of adipocytes exposed to TCM; ACM, culture 
supernatant of adipocytes exposed to CM; TCM, culture supernatant of BPH epithelial cells exposed to T. vaginalis; CM, culture super-
natant of BPH epithelial cells; Leptin, recombinant leptin; Medium, culture medium of prostate cells.
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sured by BrdU and wound healing assay. The ATCM contain-
ing higher amount of leptin than other conditioned media in-
creased wound healing (P<0.05; Fig. 4A, D) and number of 
BrdU positive cells (Fig. 4B, E) in both prostate cells. Our data 
suggest that ATCM stimulates the proliferation of prostate stro-
mal and BPH epithelial cells. Interestingly, WPMY-1 cells treat-
ed with ATCM were observed to have slightly increased prolif-
eration compared to the results of BPH-1 cells. In addition, al-
though no invasiveness was observed in BPH-1 cells, WPMY-1 
cells showed increased invasiveness (Fig. 4C). In BPH tissue, 
proliferation is known to be observed 9 times in epithelial 
cells and 37 times in stromal cells compared to normal pros-
tate, and the overgrowth of the stromal cells is recognized as a 
characteristic of BPH pathogenesis [33]. In this experiment, 
the increased mobility, multiplication and invasiveness of the 
prostate stromal cell were in line with the characteristics of 
BPH tissue.
Expression of leptin signaling molecules in prostate cells 
exposed to ATCM
Leptin binding to OBR has been reported to activate the 













































































Fig. 4. Increased proliferation of prostate cells incubated with ATCM. Wound healing and BrdU assays were used to measure the prolif-
eration of prostate stromal cells (WPMY-1) and BPH epithelial cells (BPH-1) incubated with ATCM. Wound healing was observed with an 
inverted microscope (A, D) and DNA synthesis in proliferating cells was assessed with the bromodeoxyuridine (BrdU) assay. BrdU-posi-
tive cells were observed by fluorescence microscopy (B, E). To investigate the effect of ATCM on invasiveness, the matrigel invasion as-
say was used. WPMY-1 cells were more invasive towards ATCM than towards medium or ACM (C). ATCM, culture supernatant of adi-
pocytes incubated with TCM; ACM, culture supernatant of adipocytes incubated with CM; TCM, culture supernatant of BPH epithelial 
cells incubated with T. vaginalis; CM, culture supernatant of BPH epithelial cells; Medium, culture medium used for all prostate cells. 
*P<0.05 versus ATCM.
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stimulates proliferation, angiogenesis, and anti-apoptotic 
events in normal and malignant cells expressing OBR. Leptin 
signaling also interacts with Notch, which is involved in tumor 
progression [23,34]. To probe whether the leptin signaling 
molecules are induced by ATCM, protein levels of leptin sig-
naling molecules were measured in the prostate cells incubat-
ed with ATCM. Downstream leptin signaling components 
such as JAK2/STAT3, Notch1/Jagged1, and survivin also in-
creased in response to ATCM in both sets of prostate cells 
(prostate stromal and BPH-1 cells) (Fig. 5). Similar results were 
obtained when recombinant leptin was used.
Inhibition of OBR reduces expression of leptin signal 
molecules and proliferation of Prostate cells
To investigate the role of OBR in leptin signaling of prostate 
cells exposed to ATCM, the cells were treated with ATCM to-
gether with anti-OBR antibody. Production of JAK2/STAT3 and 
Notch/Jagged was markedly inhibited by the anti-OBR anti-
body (P<0.05; Fig. 6). This indicates that ATCM activates the 
leptin signal pathway via OBR. When the OBR was blocked, 
ATCM-induced proliferation of prostate cells also decreased. 
Moreover, inhibition of leptin downstream signaling using a 
JAK inhibitor (ruxolitinib) or a Notch inhibitor (DAPT) re-
duced prostate cell proliferation (P<0.05; Fig. 7), which shows 
that the leptin signaling pathway contributes to proliferation. 
The use of isotype-matched antibodies as a control had no ef-
fect on cell proliferation (data not shown). Our findings indi-
cate that leptin-OBR signaling is involved in the proliferation 
of WPMY-1 and BPH-1 cells.
OBR expression slightly increased in BPH tissue in obese 
BPH patients compared to lean patients
A total of 94 patients with benign prostatic hyperplasia who 
underwent surgical resection in Hanyang University Hospital 
(Seoul, Korea) from 2016 to 2018 were identified. Among 
them, ten obese and 10 lean patients were categorized by BMI 
level. The patients whose mean of BMI level was 28 classified 
into the obese group. The lean group has had an average BMI 
level of 23. OBR expression was detected immunohistochemi-
cally with rabbit polyclonal anti-OBR antibody. Intensity of 
OBR expression was represented as a numerical score from 0 to 
5 based on proportion of clusters of immunopositive cells. The 
OBR was slightly more expressed in human BPH tissue from 
obese patients than lean patients (Fig. 8).
DISCUSSION
Trichomonas vaginalis is mostly known as a surface-dwelling 
parasite, but it has been detected in endo-epithelial cells and 
in sub-epithelial tissues because of its ability to invade [5,6]. 
A B 
Fig. 5. Increased expression of leptin signaling molecules in prostate cells exposed to ATCM. Expression of leptin signaling molecules 
such as JAK2/STAT3, Notch1/Jagged1, NICD and survivin was increased by treatment with ATCM or recombinant leptin in prostate 
stromal (A) and BPH-1 cells (B). ATCM, culture supernatant of adipocytes exposed to TCM; ACM, culture supernatant of adipocytes ex-
posed to CM; TCM, culture supernatant of BPH epithelial cells exposed to T. vaginalis; CM, culture supernatant of BPH epithelial cells; 
Leptin, recombinant leptin; Medium, culture medium of prostate cells; NICD, Notch intracellular domain.
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Fig. 6. Blockade of the leptin receptor reduces the expression of downstream signaling molecules in prostate cells stimulated with ATCM. 
To investigate the expression of downstream leptin signaling molecules in prostate cells exposed to ATCM, prostate stromal cells (WPMY-1) 
and BPH epithelial cells (BPH-1) were incubated with ATCM or ATCM+anti-OBR antibody (α-OBR). Protein and mRNA levels were mea-
sured by western blot (A, C) and Q-PCR (B, D), respectively. ATCM, culture supernatant of adipocytes incubated with TCM; ACM, culture 
supernatant of adipocytes incubated with CM; TCM, culture supernatant of BPH epithelial cells incubated with T. vaginalis; Medium, culture 
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Because T. vaginalis infection has been found in over 70% of 
the male sexual partners of infected women, the number of 
infected men must be not ignored [35]. 19.9% of male non-
gonococcal urethritis (NGU) patients were reported to be in-
fected with T. vaginalis, and BPH may be associated with 
chronic retention of T. vaginalis in the prostate gland [5,36]. 
Microenvironmental factors such as infection and wounding 
may alter cellular equilibria leading to BPH or prostate cancer 
[37]. A little is known about the proliferative mechanism of 
prostate cells. Siejka et al. [38] reported that bidirectional stro-
mal-epithelial interactions occur in the prostate gland; when 
supernatants of prostate stromal cells (or BPH epithelial cells) 
were added to BPH epithelial cells (or prostate stromal cells), 
proliferation increased. In this context, our previous studies 
showed that the proliferation of inflamed BPH epithelial cells 
infected with T. vaginalis induced the multiplication of prostate 
stromal cells via crosstalk with mast cells, and IL-6 released by 
the proliferating prostate stromal cells stimulated the prolifera-
tion of BPH epithelial cells [26,27].
As people’s lifestyles have changed, obesity has become an 
important issue even in Asia. Obesity is related to social prob-
lems as well as personal health care. It causes many diseases, 
and is closely linked to diabetes, hypertension, malignancy, 
etc. [39]. Adipose tissue affects the endocrine and immune sys-
tems by secreting cytokines and hormones. These cytokine-like 
mediators produced by adipose tissue are called adipokines, 
and include leptin, adiponectin and resistin [40]. Leptin was 
first identified as a key molecule in the regulation of food in-
Fig. 7. Inhibition of leptin signaling decreases the proliferation of prostate cells. To confirm the involvement of leptin signaling in the 
growth of prostate stromal (WPMY-1) and BPH epithelial (BPH-1) cells, the leptin receptor (OBR), JAK or Notch were inhibited, and the 
wound healing assay was conducted. Anti-OBR antibody (α-OBR) and the JAK inhibitor (ruxolitinib) and Notch inhibitor (DAPT) de-
creased the proliferation of both prostate cell types in response to ATCM. ATCM, culture supernatant of adipocytes incubated with TCM; 
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Fig. 8. Leptin receptor (OBR) expression slightly increased in BPH tissue in obese BPH patients compared to lean patients. OBR ex-
pression was detected immunohistochemically with rabbit polyclonal anti-OBR antibody. Intensity of OBR expression was represented 
as a numerical score from 0 to 5 based on proportion of clusters of immunopositive cells. The OBR was slightly more expressed in hu-
man BPH tissue from obese patients than lean patients. Bar=200 μm.
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take and body weight. It also has a role in wound healing, re-
production, hematogenesis, and regulation of insulin and tes-
tosterone [41,42].
Clinical BPH, a condition involving abnormal progressive 
growth of prostate tissue is a common disease in elderly men, 
and causes lower urinary tract syndrome [43]. As the average 
human lifespan increases, it is becoming recognized as an im-
portant disease that affects quality of life and in which BPH, 
hormonal alterations, metabolic syndrome and obesity play 
key roles [13-15]. Obesity, central or general, is thought to be 
a risk factor for BPH [17]. The molecular mechanisms associ-
ated with the progression and aggravation of BPH in obesity 
are not known. In this study, we investigated whether BPH 
proliferation was induced by adipocyte leptin, which was 
stimulated by T. vaginalis infection in prostate cells.
The role of leptin has been much studied in breast cancer; 
Leptin may act via JAK/STAT signaling to increase breast cancer 
tissue proliferation [44]. It has been implicated in the higher 
incidence of aggressiveness, and appears to be involved in the 
proliferation and migration of breast cancer cells [45]. Guo et 
al. [46] have been reported that leptin induces Notch, and the 
Notch target gene, IL-1, and VEGF, and their levels of these 
molecules in breast cancers are correlated with the occurrence 
of metastases and lower survival. However, the function of 
leptin in the prostate has not been much studied. There are a 
few reports that leptin is associated with proliferation of the 
prostate; Leptin seems to have an important role in maintain-
ing the physiological growth of the prostate. In hyperplasic 
prostate tissue, leptin treatment increased cellular proliferation 
and decreased apoptosis [47]. It is also reported to stimulate 
the proliferation of a BPH-1 cell and a prostate cancer cell line 
(PC-3 cell) via estrogen metabolism [48]. Leptin expression in 
prostate cancer tissue is significantly higher than in BPH, al-
though expression of the leptin receptor (OBR) was similar in 
BPH and prostate cancer tissue [31]. Therefore, it was recently 
suggested that leptin might be a novel target for therapeutic 
intervention in prostatic disorders [48]. In agreement with the 
above reports, proliferation of prostate cells in our study was 
upregulated upon exposure to adipocyte-conditioned medium 
(ATCM) which contained leptin, and inhibition of the OBR 
reduced leptin-induced proliferation. Thus, this study provides 
the first experimental evidence that the leptin-OBR signal 
pathway plays a role in prostate cell proliferation.
There are 6 isoforms of OBR, which exerts various physio-
logical effects in response to binding by leptin, which is a 16 
kDa non-glycosylated protein encoded by the Ob gene [49]. 
OBR belongs to a superfamily of class I cytokine receptors, 
which typically contain a cytokine receptor-homologous do-
main in their extracellular regions [19]. As with other class I 
cytokine receptors, the leptin signal is reported to be transmit-
ted mainly by the JAK/STAT pathway. Binding of leptin to OBR 
leads to tyrosine phosphorylation of JAK1 and JAK2, and 
phosphorylation of downstream STAT transcription factors 
[50]. In the case of lung cancer cell, leptin was shown to pro-
mote growth, invasiveness, and migration with concomitant 
activation of JAK/STAT, PI3K/AKT and ERK signaling [22]. In 
this study, adipocyte leptin was found to stimulate the OBR 
and the JAK2/STAT3 signal pathway in prostate cells; inhibi-
tion of the OBR and JAK decreased leptin-induced prolifera-
tion of prostate cells. Besides, the OBR was slightly more ex-
pressed in BPH tissue in obese than in lean patients (Fig. 8).
Notch is a downstream signal of leptin, and is highly con-
served in evolution. The Notch signal is very important in de-
termining cell-fate decisions from proliferation, differentiation 
and apoptosis to cancer cell invasion and metastasis [51]. The 
Notch family consists of 4 receptors (Notch 1-4) and has 5 li-
gands named Jagged 1, 2, Delta-like 1, 3, and 4 [22]. In re-
sponse to ligand binding, the Notch receptor undergoes pro-
teolytic cleavage, resulting in the release of the Notch intracel-
lular domain (NICD). NICD then enters the nucleus and 
forms a complex with RBP-jκ (also known as CSL) and his-
tone acetyltransferase (CBP/p300) leading to the expression of 
Notch target genes such as survivin [52]. The notch signal has 
been reported to play critical roles in intraepithelial neoplasia 
formation in prostate cancer, and in proliferation and angio-
genesis in breast and pancreatic cancers [53,54]. But the Notch 
signal hitherto had no known role in BPH enlargement. In 
this study, the leptin-OBR signal activated Notch signaling, 
and inhibition of Notch reduced the proliferation of prostate 
stromal cells and BPH epithelial cells. This result suggests for 
the first time that Notch signaling may be involved in the pro-
liferation of BPH cells via the leptin-OBR signal pathway. 
Meanwhile, Mullen et al. [23] proposed a signal cascade that 
leptin induces Notch in breast cancer through JAK2/STAT3. Al-
though our study revealed that JAK2/STAT3 is involved in the 
leptin-OBR signaling pathway, the signaling cascade has not 
been well documented. Further research is needed.
Survivin, a member of the inhibitor-of-apoptosis protein 
family, mainly acts to suppress apoptosis and regulate cell di-
vision [55]. Although not expressed in normal adult differenti-
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ated tissue, it is present in most cancers, regardless of lineage, 
differentiation and histological type [56]. Survivin expression 
correlates with unfavorable disease outcomes through in-
creased aggressiveness and metastasis in colorectal, pancreatic, 
breast and ovarian cancers [55,57,58]. Downstream effector 
molecules of leptin signaling (such as Stat3 and Akt) are re-
ported to participate in the regulation of survivin expression 
[59]. In our case, expression of survivin increased in response 
to ATCM. Inhibition of the leptin-OBR pathway reduced sur-
vivin levels and consequently decreased leptin-induced prolif-
eration of the prostate cells. This result is probably the first evi-
dence that survivin is involved in the leptin-induced prolifera-
tion of prostate cells.
In summary, inflammatory mediators released by BPH epi-
thelial cells in response to infection with T. vaginalis induce 
migration and activation of adipocytes. The activated adipo-
cytes then stimulate the proliferation of prostate cells through 
leptin-OBR signaling. Therefore, it is likely that T. vaginalis 
contributes to prostate enlargement via adipocyte leptin re-
leased as a result of inflammation of the prostate (Fig. 9).
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